Skip to main content

Healios K.K. to Present at the 2025 Jefferies Global Healthcare Conference

Written by Customer Service on . Posted in Public Companies.

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — HEALIOS K.K. (“Healios”) is pleased to announce that Richard Kincaid, Chief Financial Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City as follows:

Date & Time:
  Thursday, June 5, 2025
  2:35pm, Eastern Standard Time (US)

Webcast:
https://wsw.com/webcast/jeff319/6vx.f/1867328

To schedule a 1×1 meeting with Healios, please contact your Jefferies representative at healthcareconference@jefferies.com.

The live and archived webcast will be accessible from Jefferies’ website. The replay of the webcast will be accessible for 60 days.

About Healios:
Healios K.K. is Japan’s leading clinical stage biotechnology company harnessing the potential of stem cells for regenerative medicine. Healios is a pioneer in the development of regenerative medicines in Japan and owns proprietary, global platforms utilizing both somatic stem cells and iPS cells. In the somatic stem cell field, Healios is developing invimestrocel (HLCM051), a proprietary cell product comprised of multipotent adult progenitor cells (“MAPCs”) derived from the bone marrow of healthy adult donors. Healios is advancing invimestrocel on a global basis for ischemic stroke, ARDS, and trauma. The company has confirmed its path to conditional approval in Japan for the use of invimestrocel for ARDS and is preparing to file for approval and for commercial launch. Healios was established in 2011 and has been listed on the Tokyo Stock Exchange since 2015 (TSE Growth: 4593). https://www.healios.co.jp/en

Contact:

U.S. Investor Relations:
Lisa M. Wilson
T: 212-452-2793
E: lwilson@insitecony.com

Richard Kincaid
Executive Officer and Chief Financial Officer
E-mail: ir@healios.jp

Company Name:
Representative:		     HEALIOS K.K.
Hardy TS Kagimoto, Chairman & CEO
(TSE Growth Code: 4593)
   

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.